Picture1.png
CBIH advances Cancer Care with Novel Cannabis Patents for Breast and Pancreatic Cancers
July 01, 2024 08:00 ET | CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
Cannabis Bioscience International Holdings (OTCMKTS: CBIH) is excited to announce the submission of our inaugural pair of patents, focusing on novel treatm
CBIH Announces Strategic Advancements Initiated by Recently Appointed Director, Setting a New Paradigm and Driving Visionary Change
June 26, 2024 10:52 ET | CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
As CBIH prepares for the manufacturing and distribution of its products, the potential collaboration might involve this entity acting as CBIH's distributor
Unleashing the Potential of Cannabis: Cannabis Bioscience International Holdings Reaches a Historic Valuation
June 17, 2024 09:50 ET | CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
CBIH a company dedicated to medicinal cannabis research for over 15 years, has achieved a 2 billion dollar valuation.
Relevium_LOGO_200.jpg
Relevium Ships First Purchase Order Release of $130,000 to Middle East Customer
March 03, 2020 11:45 ET | Relevium Technologies Inc
MONTREAL, March 03, 2020 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that the Company’s...
Relevium_LOGO_200.jpg
Relevium Reports Improved Financial Results for Second Quarter of Fiscal 2020  
March 02, 2020 08:30 ET | Relevium Technologies Inc
MONTREAL, March 02, 2020 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to report second quarter results...
Relevium_LOGO_200.jpg
Relevium Launches LeefyLyfe™ Organic Hemp Products in the US
November 20, 2019 09:18 ET | Relevium Technologies Inc
MONTREAL, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the launch of...
Relevium_LOGO_200.jpg
Relevium Executes LOI to Acquire Montreal Biopharma Contract Manufacturing Company
November 08, 2019 08:35 ET | Relevium Technologies Inc
MONTREAL, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce it has executed a...
Relevium_LOGO_200.jpg
Relevium’s Subsidiary BGX E-Health Secures One Million Dollar Export Contract for the Middle East
October 30, 2019 09:30 ET | Relevium Technologies Inc
MONTREAL, Oct. 30, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that its wholly owned...
Relevium_LOGO_200.jpg
Relevium Enters Into LOI to Unlock Value of Wholly Owned Subsidiary BGX E-Health LLC and Announces Conference Call With CEO
October 29, 2019 09:22 ET | Relevium Technologies Inc
MONTREAL, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce On October 25, 2019,...
green logo.jpg
GreenGro Technologies, Inc. Unveils Proprietary Newly Developed Breed of Hemp
October 18, 2019 05:00 ET | Greengro Technologies
ANAHEIM, Calif., Oct. 18, 2019 (GLOBE NEWSWIRE) -- GreenGro Technologies, Inc. (OTC: GRNH), is pleased to announce that the Company’s wholly owned subsidiary, CBD Ventures has successfully developed...